Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
华尔街最准确的分析师聚焦于3只医疗保健股票，提供高股息收益。
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市场动荡和不确定性时期，许多投资者都会转向具有股息收益的股票。这些往往是拥有高自由现金流并向股东支付高股息的公司。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的读者可以查看我们的分析师股票评级页面，查看最新的分析师对他们最喜爱的股票的看法。交易员可以浏览Benzinga的广泛分析师评级数据库，包括按分析师准确性排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是医疗保健板块三只高收益股票最准确的分析师评级。
Pfizer Inc. (NYSE:PFE)
辉瑞公司(NYSE:PFE)
- Dividend Yield: 5.88%
- Barclays analyst Carter Gould maintained an Equal-Weight rating and raised the price target from $30 to $32 on July 31. This analyst has an accuracy rate of 60%.
- Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and boosted the price target from $28 to $30 on July 31. This analyst has an accuracy rate of 78%.
- Recent News: On Monday, Pfizer released top-line safety and immunogenicity results from substudy B of the ongoing pivotal MONeT Phase 3 trial,evaluating two doses of Abrysvo vaccine in immunocompromised adults aged 18 and older at risk of developing severe respiratory syncytial virus-associated lower respiratory tract disease.
- Benzinga Pro's real-time newsfeed alerted to latest PFE news
- 股息收益率：5.88%
- 巴克莱银行分析师Carter Gould于7月31日维持Equal-Weight评级，将价格目标从30美元上调至32美元。该分析师的准确率为60%。
- 威尔斯·法戈分析师Mohit Bansal于7月31日维持Equal-Weight评级，将价格目标从28美元上调至30美元。该分析师的准确率为78%。
- 最近新闻：辉瑞公司在进行重大MONet 3期临床试验的子研究b中发布了Abrysvo疫苗两种剂量在18岁及以上的免疫功能低下的成年人中评估严重呼吸合胞病毒相关的下呼吸道疾病的安全性和免疫原性结果的首要安全性和免疫原性结果。
- Benzinga Pro的实时新闻提醒了最新的PFE新闻
GSK plc (NYSE:GSK)
GSK股票（NYSE：GSK）
- Dividend Yield: 3.80%
- Jefferies analyst Peter Welford maintained a Buy rating and raised the price target from $52.5 to $53 on July 2. This analyst has an accuracy rate of 70%.
- Guggenheim analyst Seamus Fernandez upgraded the stock from Neutral to Buy on March 4. This analyst has an accuracy rate of 62%.
- Recent News: On July 31, GSK reported second-quarter sales of $9.95 billion (7.88 billion Sterling Pounds), up 10% year-over-year and 13% on constant currency..
- Benzinga Pro's charting tool helped identify the trend in GSK stock.
- 股息收益率：3.80%
- 杰富瑞证券分析师Peter Welford于7月2日维持买入评级，将价格目标从52.5美元上调至53美元。该分析师的准确率为70%。
- 古根海姆分析师Seamus Fernandez于3月4日将该股票的评级由中立上调至买入。该分析师的准确率为62%。
- 最近的新闻：7月31日，GSK报告第二季度销售额为99.5亿美元（78.8亿英镑），同比增长10％，按恒定汇率计算增长13％。
- Benzinga Pro的制图工具有助于识别出GSK股票的趋势。
CVS Health Corporation (NYSE:CVS)
西维斯健康公司（纽约证券交易所股票代码：CVS）
- Dividend Yield: 4.66%
- Deutsche Bank analyst George Hillmaintained a Hold rating and cut the price target from $64 to $63 on Aug. 9. This analyst has an accuracy rate of 60%.
- Barclays analyst Andrew Mok maintained an Equal-Weight rating and slashed the price target from $65 to $63 on Aug. 8. This analyst has an accuracy rate of 66%.
- Recent News: On Aug. 7, CVS Health reported mixed second-quarter earnings and cut annual profit guidance.
- Benzinga Pro's signals feature notified of a potential breakout in CVS shares.
- 股息收益率：4.66%
- 德意志银行分析师George Hill于8月9日维持持有评级，将价格目标从64美元下调至63美元。该分析师的准确率为60%。
- 巴克莱银行分析师Andrew Mok于8月8日维持Equal-Weight评级，将价格目标从65美元下调至63美元。该分析师的准确率为66%。
- 最近新闻：8月7日，西维斯健康报告了二季度收益不佳，并下调了年度利润指引。
- Benzinga Pro的信号特征指出CVS股票的潜在突破。
Read More:
阅读更多：
- Dow Settles Higher But Records Weekly Loss: Greed Index Remains In 'Extreme Fear' Zone
- 道琼斯收涨，但本周下跌：贪婪指数仍处于“极度恐惧”区域。